Evaluation of standard and enhanced quality improvement methods to increase the uptake of magnesium sulfate in preterm deliveries for the prevention of neurodisability (PReCePT Study): a cluster randomized controlled trial
Authors:
- Hannah B EdwardsHEHannah B Edwards
- Maria Theresa RedanielMRMaria Theresa Redaniel
- Carlos Sillero-RejonCSCarlos Sillero-Rejon
- Christalla Pithara-McKeownCPChristalla Pithara-McKeown
- Ruta MargelyteRMRuta Margelyte
- Tracey StoneTSTracey Stone
- Tim J PetersTPTim J Peters
- William HollingworthWHWilliam Hollingworth
- Hugh McLeodHMHugh McLeod
- Sabi RedwoodSRSabi Redwood
Preprint
Abstract
Objective: To compare the impact of the National PReCePT Programme (NPP) versus an enhanced Quality Improvement (QI) support programme in improving magnesium sulfate (MgSO 4 ) uptake in English maternity units. Design: Unblinded cluster randomised controlled trial. Setting: England, Academic Health Sciences Network (AHSN), 2018. Participants: Maternity units with ≥10 preterm deliveries annually and MgSO 4 uptake ≤70%. 40 maternity units (27 NPP, 13 enhanced support) were included (randomisation stratified by MgSO 4 uptake). Interventions: NHS England commissioned the NPP to increase MgSO 4 uptake in very preterm deliveries to reduce risk of cerebral palsy. NPP maternity units received PReCePT QI materials, regional support, and midwife backfill funding. Enhanced support units received this plus extra backfill funding and unit-level QI coaching. Outcome measures: MgSO 4 uptake post-implementation was compared between groups using routine data and multivariable linear regression. Net monetary benefit was estimated, based on implementation costs, lifetime quality-adjusted life-years and societal costs. The implementation process was assessed through qualitative process evaluation. Results: MgSO 4 uptake increased in all units, with no evidence of difference between groups (0.84 percentage points lower uptake in the enhanced group, 95% Confidence Interval -5.03 to 3.35 percentage points). The probability of enhanced support being cost-effective was 4 uptake in all maternity units. Enhanced support did not further improve uptake but may improve teamwork, and more accurately represented the time needed for implementation. Targeted enhanced support, sustainability of improvements and the possible indirect benefits of stronger teamwork associated with enhanced support should be explored further. Trial registration: ISRCTN 40938673 ( https://www.isrctn.com/ISRCTN40938673 ) WHAT IS ALREADY KNOWN ON THIS TOPIC: Despite long-standing evidence that Magnesium Sulfate (MgSO 4 ) confers fetal neuroprotection and reduces risk of cerebral palsy in very preterm babies, by 2017 only two-thirds of eligible women in England were receiving it, with wide regional variation. The pilot PReCePT (Prevention of Cerebral Palsy in preterm labour) Quality Improvement (QI) study appeared to effectively accelerate uptake of MgSO 4, and a version of this support model was rolled-out nationwide in 2018. WHAT THIS STUDY ADDS: PReCePT improved MgSO 4 uptake in all maternity units, and the full (‘enhanced’) support model did not appear to improve uptake beyond the achievements of the standard support model used in the National PReCePT Programme. However, enhanced support may be associated with improved perinatal team working, and the funding more accurately represented the staff time needed for implementation. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY: PReCePT may serve as a blueprint for other improvement programs to accelerate uptake of evidence-based interventions, and future studies should consider the potential for indirect but far-reaching benefits to staff and patients.Keywords
This publication has 21 references indexed in Scilit:
- Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infantsScientific Reports, 2015
- Outcomes in preterm infantsPublic Health, 2014
- Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysisBMC Health Services Research, 2013
- Using the framework method for the analysis of qualitative data in multi-disciplinary health researchBMC Medical Research Methodology, 2013
- Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studiesBMJ, 2012
- Audit and feedback: effects on professional practice and healthcare outcomesCochrane Database of Systematic Reviews, 2012
- Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic reviewThe Lancet, 2012
- Normalisation process theory: a framework for developing, evaluating and implementing complex interventionsBMC Medicine, 2010
- Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetusCochrane Database of Systematic Reviews, 2009
- The epidemiology of cerebral palsy: Incidence, impairments and risk factorsDisability and Rehabilitation, 2006